The DOI matches its Crossref record; 75 of the 77 references it cites were found in a registry or an index.
Antitumor effect of oncolytic virus and paclitaxel encapsulated in extracellular vesicles for lung cancer treatment
Open accessAbstract
Standard of care for cancer is commonly a combination of surgery with radiotherapy or chemoradiotherapy. However, in some advanced cancer patients this approach might still remaininefficient and may cause many side effects, including severe complications and even death. Oncolytic viruses exhibit different anti-cancer mechanisms compared with conventional therapies, allowing the possibility for improved effect in cancer therapy. Chemotherapeutics combined with oncolytic viruses exhibit stronger cytotoxic responses and oncolysis. Here, we have investigated the systemic delivery of the oncolytic adenovirus and paclitaxel encapsulated in extracellular vesicles (EV) formulation that, in vitro, significantly increased the transduction ratio and the infectious titer when compared with the virus and paclitaxel alone. We demonstrated that the obtained EV formulation reduced the in vivo tumor growth in animal xenograft model of human lung cancer. Indeed, we found that combined treatment of oncolytic adenovirus and paclitaxel encapsulated in EV has enhanced anticancer effects both in vitro and in vivo in lung cancer models. Transcriptomic comparison carried out on the explanted xenografts from the different treatment groups revealed that only 5.3% of the differentially expressed genes were overlapping indicating that a de novo genetic program is triggered by the presence of the encapsulated paclitaxel: this novel genetic program might be responsible of the observed enhanced antitumor effect. Our work provides a promising approach combining anticancer drugs and viral therapies by intravenous EV delivery as a strategy for the lung cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, Garofalo et al. showed lung tumor cell-derived exosomes can effectively carry the oncolytic virus and chemotherapeutic drugs (PTX), thus enhancing the antitumor effects in nude mice [57].”
From The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System (2022) · cites this paper as [57]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
STAR: ultrafast universal RNA-seq aligner
Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M., & Gingeras, T. R. (2013) · Bioinformatics · doi:10.1093/bioinformatics/bts635 · Cited by 51,709
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145
Biological properties of extracellular vesicles and their physiological functions
Yáñez‐Mó, M., Siljander, P. R. ‐., Andreu, Z., Bedina Zavec, A., Borràs, F. E., Buzas, E. I., Buzas, K., Casal, E., Cappello, F., Carvalho, J., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27066 · Cited by 5,926
Tumour exosome integrins determine organotropic metastasis
Hoshino, A., Costa-Silva, B., Shen, T.-L., Rodrigues, G., Hashimoto, A., Tesic Mark, M., Molina, H., Kohsaka, S., Di Giannatale, A., Ceder, S., et al. (2015) · Nature · doi:10.1038/nature15756 · Cited by 5,101
Genesis: cluster analysis of microarray data
Sturn, A., Quackenbush, J., & Trajanoski, Z. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.1.207 · Cited by 1,761
Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper
Lener, T., Gimona, M., Aigner, L., Börger, V., Buzas, E., Camussi, G., Chaput, N., Chatterjee, D., Court, F. A., del Portillo, H. A., et al. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.30087 · Cited by 1,491
Extracellular vesicles for drug delivery.
Vader, P., Mol, E. A., Pasterkamp, G., & Schiffelers, R. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.02.006 · Cited by 1,319
Research works printed but not linked: 9
- Zhao, 2003, Adenovirus with insertion-mutated E1A selectively propagates in liver Cancer cells and destroys tumors in vivo advances in brief adenovirus with insertion-mutated E1A selectively propagates in liver Cancer cells and destroys tumors in vivo 1, Cancer Res., 3073
- Liebert, 1999, vol. 3029, 3013
- Eisenberg, 2007, 8, 603
- Rizvi, 2018, vol. 26, 639
- Chen, 2015, vol. 27, 190
- Bertoli, 2015, 14, 518
- Seymour, 2016, 114, 357
- Kooijmans, 2016, 224, 77
- Kim, 2017, HHS public, Access, 12, 655
Cited by
Sorted by citations
Advances and challenges in the treatment of lung cancer
Li, Y., Yan, B., & He, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115891 · Cited by 492
Oncolytic Viruses and the Immune System: The Dynamic Duo
de Matos, A. L., Franco, L. S., & McFadden, G. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.01.001 · Cited by 289
Preservation of biomaterials and cells by freeze-drying: Change of paradigm
Merivaara, A., Zini, J., Koivunotko, E., Valkonen, S., Korhonen, O., Fernandes, F. M., & Yliperttula, M. L. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.06.042 · Cited by 225
Self-citationExtracellular vesicles as a drug delivery system: A systematic review of preclinical studies
de Castilla, P. E. M., Tong, L., Huang, C., Sofias, A. M., Pastorin, G., Chen, X. S., Storm, G., Schiffelers, R. M., & Wang, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.011 · Cited by 219
Garofalo, M., Villa, A. M., Rizzi, N., Kuryk, Ł., Rinner, B., Cerullo, V., Yliperttula, M. L., Mazzaferro, V., & Ciana, P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.022 · Cited by 138
Self-citationExtracellular Vesicles as Natural, Safe and Efficient Drug Delivery Systems
Villa, F., Quarto, R., & Tasso, R. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11110557 · Cited by 129
Extracellular vesicles as bioactive nanotherapeutics: An emerging paradigm for regenerative medicine
Li, M., Fang, F., Sun, M., Zhang, Y., Hu, M., & Zhang, J. (2022) · Theranostics · doi:10.7150/thno.72812 · Cited by 121
Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy
Škubník, J., Pavlíčková, V. S., Ruml, T., & Rimpelová, S. (2021) · Plants · doi:10.3390/plants10030569 · Cited by 121
The Therapeutic Potential and Clinical Significance of Exosomes as Carriers of Drug Delivery System
Li, T., Li, X., Han, G., Liang, M., Yang, Z., Zhang, C., Huang, S., Tai, S., & Yu, S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics15010021 · Cited by 110
Customized materials-assisted microorganisms in tumor therapeutics
Chen, Q., Qiao, J., Liu, X., Zhang, C., & Zhang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01571g · Cited by 109
Perspective on Adenoviruses: Epidemiology, Pathogenicity, and Gene Therapy
Crenshaw, B. J., Jones, L. B., Bell, C. R., Kumar, S., & Matthews, Q. L. (2019) · Biomedicines · doi:10.3390/biomedicines7030061 · Cited by 106
Kuryk, Ł., Møller, A. W., & Jaderberg, M. E. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1532763 · Cited by 100
Garofalo, M., Villa, A. M., Rizzi, N., Kuryk, Ł., Mazzaferro, V., & Ciana, P. (2018) · Viruses · doi:10.3390/v10100558 · Cited by 101
Self-citationExtracellular Vesicles and Viruses: Two Intertwined Entities
Moulin, C., Crupi, M. J. F., Ilkow, C. S., Bell, J. C., & Boulton, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021036 · Cited by 96
Application of engineered extracellular vesicles for targeted tumor therapy
Zhang, F., Guo, J. J., Zhang, Z., Duan, M., Wang, G., Qian, Y., Zhao, H., Yang, Z., & Jiang, X. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00798-y · Cited by 92
From Conventional Therapies to Immunotherapy: Melanoma Treatment in Review
Kuryk, Ł., Bertinato, L., Staniszewska, M., Pancer, K. W., Wieczorek, M., Salmaso, S., Caliceti, P., & Garofalo, M. (2020) · Cancers · doi:10.3390/cancers12103057 · Cited by 85
Self-citationde Jong, B., Barros, E., Hoenderop, J. G. J., & Rigalli, J. P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12111006 · Cited by 71
Tumor-derived extracellular vesicles as messengers of natural products in cancer treatment
Xu, Y., Feng, K., Zhao, H., Di, L., Wang, L., & Wang, R. (2022) · Theranostics · doi:10.7150/thno.67775 · Cited by 70
Logozzi, M., Mizzoni, D., Bocca, B., Raimo, R. D., Petrucci, F., Caimi, S., Alimonti, A., Falchi, M., Cappello, F., Campanella, C., et al. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.02.014 · Cited by 69
Development of oncolytic virotherapy: from genetic modification to combination therapy
Lan, Q., Xia, S., Wang, Q., Xu, W., Huang, H., Jiang, S., & Lu, L. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0750-4 · Cited by 66
Heterologous and cross-species tropism of cancer-derived extracellular vesicles
Garofalo, M., Villa, A. M., Crescenti, D., Marzagalli, M., Kuryk, Ł., Limonta, P., Mazzaferro, V., & Ciana, P. (2019) · Theranostics · doi:10.7150/thno.34824 · Cited by 67
Self-citationKim, M. W., Kwon, S., Choi, J. H., & Lee, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123859 · Cited by 64
Extracellular vesicles provide a capsid‐free vector for oncolytic adenoviral DNA delivery
Saari, H., Turunen, T. A., Lõhmus, A., Turunen, M. P., Jalasvuori, M., Butcher, S. J., Ylä‐Herttuala, S., Viitala, T., Cerullo, V., Siljander, P. R. M., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1747206 · Cited by 65
Self-citationIpinmoroti, A. O., & Matthews, Q. L. (2020) · Pathogens · doi:10.3390/pathogens9121056 · Cited by 62
Jayasinghe, M. K., Tan, M., Peng, B., Yang, Y., Sethi, G., Pirisinu, M., & Le, M. T. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.02.010 · Cited by 62
Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors
Shevtsov, M. A., Multhoff, G., Mikhaylova, E. R., Shibata, A., Guzhova, I. V., & Margulis, B. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215284 · Cited by 60
Recent advances in oncolytic virus-based cancer therapy
Fu, L., Wang, S., Cai, M., Wang, X., Chen, J., Tong, X., Chen, X., & Mou, X. (2019) · Virus Research · doi:10.1016/j.virusres.2019.197675 · Cited by 57
Transplantation of autologous extracellular vesicles for cancer-specific targeting
Villa, A. M., Garofalo, M., Crescenti, D., Rizzi, N., Brunialti, E., Vingiani, A., Belotti, P., Sposito, C., Franzè, S., Cilurzo, F., et al. (2020) · Theranostics · doi:10.7150/thno.51344 · Cited by 57
Self-citationSalmond, N., & Williams, K. C. (2021) · Nanoscale Advances · doi:10.1039/d0na00676a · Cited by 57
Li, H., Xu, W., Li, F., Zeng, R., Zhang, X., Wang, X., Zhao, S., Weng, J., Zhu, L., & Sun, L. (2022) · Drug Delivery · doi:10.1080/10717544.2021.2023697 · Cited by 56
Kim, J., Sestito, L. F., Im, S., Kim, W. J., & Thomas, S. N. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201908788 · Cited by 54
Expanding the Spectrum of Adenoviral Vectors for Cancer Therapy
Gao, J. J., Zhang, W., & Ehrhardt, A. (2020) · Cancers · doi:10.3390/cancers12051139 · Cited by 53
Role of extracellular vesicles in chronic lung disease
Trappe, A., Donnelly, S. C., McNally, P., & Coppinger, J. A. (2021) · Thorax · doi:10.1136/thoraxjnl-2020-216370 · Cited by 52
Kuryk, Ł., Møller, A. W., & Jaderberg, M. E. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25501 · Cited by 47
Kuryk, Ł., & Møller, A. W. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25677 · Cited by 44
Deng, S., Iscaro, A., Zambito, G., Mijit, E., Minicucci, M., Essand, M., Löwik, C. W. G. M., Muthana, M., Censi, R., Mezzanotte, L., et al. (2021) · Nanomaterials · doi:10.3390/nano11010144 · Cited by 43
Wang, M., Lv, C.-Y., Li, S., Wang, J.-K., Luo, W., Zhao, P., Liu, X., Wang, Z., Jiao, Y., Sun, H., et al. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-00907-3 · Cited by 42
Zhang, Y., Wu, J., Zhang, H., Wei, J., & Wu, J. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.574007 · Cited by 40
Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies
Dogrammatzis, C., Waisner, H., & Kalamvoki, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00376 · Cited by 39
Garofalo, M., Grazioso, G., Cavalli, A., & Sgrignani, J. (2020) · Molecules · doi:10.3390/molecules25071756 · Cited by 39
Self-citationMechanisms of extracellular vesicle uptake and implications for the design of cancer therapeutics
Jackson, S. R., Flemming, J. P., Karagoz, K., Wermuth, P. J., & Mahoney, M. G. (2024) · Journal of Extracellular Biology · doi:10.1002/jex2.70017 · Cited by 42
Zocchi, M. R., Tosetti, F., Benelli, R., & Poggi, A. D. (2020) · Cancers · doi:10.3390/cancers12071886 · Cited by 35
Microbial dysbiosis and epigenetics modulation in cancer development – A chemopreventive approach
Haque, S., Raina, R., Afroze, N., Hussain, A., Alsulimani, A., Singh, V., Mishra, B. N., Kaul, S., & Kharwar, R. N. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.06.024 · Cited by 35
Cheng, C. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c00185 · Cited by 35
Yin, Z., Fan, J., Xu, J., Wu, F., Yang, L., Zhou, M. L., Liao, T., Duan, L., Wang, S., Geng, W., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02024 · Cited by 34
From Immunosuppression to Immunomodulation - Turning Cold Tumours into Hot
Garofalo, M., Pancer, K. W., Wieczorek, M., Staniszewska, M., Salmaso, S., Caliceti, P., & Kuryk, Ł. (2022) · Journal of Cancer · doi:10.7150/jca.71992 · Cited by 32
Self-citationNF-κB Signaling in Targeting Tumor Cells by Oncolytic Viruses—Therapeutic Perspectives
Struzik, J., & Szulc‐Dąbrowska, L. (2018) · Cancers · doi:10.3390/cancers10110426 · Cited by 31
Multifunctional Applications of Engineered Extracellular Vesicles in the Treatment of Cancer
Kugeratski, F. G., McAndrews, K. M., & Kalluri, R. (2021) · Endocrinology · doi:10.1210/endocr/bqaa250 · Cited by 27
Formulation-optimized oncolytic viruses: Advancing systemic delivery and immune amplification
Ma, N., Gao, J., Pang, X., Wu, K., Yang, S., Wei, H. L., & Hao, Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.113822 · Cited by 30
Chatterjee, S., Kordbacheh, R., & Sin, J. (2024) · Microorganisms · doi:10.3390/microorganisms12020274 · Cited by 26
Emerging delivery strategy for oncolytic virotherapy
Zhu, J., Ma, J., Huang, M., Deng, H., & Shi, G. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200809 · Cited by 25
Strategies for Small Extracellular Vesicle-Based Cancer Immunotherapy
Chen, Y., Tang, S., Cai, F., & Wan, Y. (2024) · Research · doi:10.34133/research.0421 · Cited by 26
Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System
Zhang, L.-Y., Yang, X., Wang, S., Chen, H., Pan, H., & Hu, Z. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200922113054 · Cited by 28
Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer
Aramini, B., Masciale, V., Grisendi, G., Banchelli, F., D’Amico, R., Dominici, M., & Haider, K. H. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_31-1 · Cited by 25
Lung cancer and oncolytic virotherapy——enemy's enemy
Li, Z., Feiyue, Z., Li, G., & Haifeng, L. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101563 · Cited by 25
Progress in oncolytic viruses modified with nanomaterials for intravenous application
Chen, L., Ma, Z., Chen, X., Xie, Y., Ouyang, D., Song, S., Zhao, X., & Liu, F. (2023) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2023.0275 · Cited by 23
Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
Kuryk, Ł., Rodella, G., Staniszewska, M., Pancer, K. W., Wieczorek, M., Salmaso, S., Caliceti, P., & Garofalo, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.916839 · Cited by 26
Self-citationExtracellular vesicles: A new frontier in deciphering the mechanisms of traditional Chinese medicine
Wang, K., He, S., Wang, Y., Guo, S., Zhang, F., Wang, Y., Dong, W., Zhang, L., Wang, X., & Yu, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107890 · Cited by 27
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation
Garofalo, M., Villa, A. M., Brunialti, E., Crescenti, D., Dell'Omo, G., Kuryk, Ł., Vingiani, A., Mazzaferro, V., & Ciana, P. (2020) · Nanotheranostics · doi:10.7150/ntno.47226 · Cited by 21
Self-citationInhalable dry powders of microRNA-laden extracellular vesicles prepared by thin-film freeze-drying
AboulFotouh, K., Almanza, G., Yu, Y., Joyce, R., Davenport, G. J., Cano, C., Williams, R. O., Zanetti, M., & Cui, Z. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123757 · Cited by 24
Mathlouthi, S., Kuryk, Ł., Prygiel, M., Lupo, M. G., Zasada, A. A., Pesce, C., Ferri, N., Rinner, B., Salmaso, S., & Garofalo, M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.057 · Cited by 21
Self-citationOptimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks
Kuryk, Ł., Møller, A. W., Vuolanto, A., Pesonen, S. A., Garofalo, M., Cerullo, V., & Jaderberg, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030621 · Cited by 21
Self-citationViral warfare: unleashing engineered oncolytic viruses to outsmart cancer’s defenses
Omolekan, T. O., Folahan, J. T., Tesfay, M. Z., Mohan, H., Dutta, O., Rahimian, L., Ferdous, K. U., Ghavimi, R., Cios, A., Beng, T. K., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1618751 · Cited by 20
An Overview on Taxol Production Technology and Its Applications as Anticancer Agent
Sharma, A., Bhatia, S. K., Banyal, A., Chanana, I., Kumar, A., Chand, D., Kulshrestha, S., & Kumar, P. (2022) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-022-0063-3 · Cited by 20
Exosomes as Novel Delivery Systems for Application in Traditional Chinese Medicine
Chen, Q., Wu, D., Wang, Y., & Chen, Z. (2022) · Molecules · doi:10.3390/molecules27227789 · Cited by 21
Liguori, G. L., & Kralj‐Iglič, V. (2023) · Cancers · doi:10.3390/cancers15184425 · Cited by 22
Haque, S., Kodidela, S., Gerth, K. A., Hatami, E., Verma, N., & Kumar, S. (2020) · Cells · doi:10.3390/cells9040864 · Cited by 19
A cell-laden hydrogel as prophylactic vaccine and anti-PD-L1 amplifier against autologous tumors
Li, J., Yan, Y., Zhang, P., Ding, J., Huang, Y., Jin, Y., & Li, L. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.09.027 · Cited by 18
Combining Oncolytic Viruses and Small Molecule Therapeutics: Mutual Benefits
Spiesschaert, B., Angerer, K., Park, J., & Wollmann, G. (2021) · Cancers · doi:10.3390/cancers13143386 · Cited by 22
Exosomes: special nano-therapeutic carrier for cancers, overview on anticancer drugs
Rezakhani, L., Fekri, K., Rostaminasab, G., & Rahmati, S. (2022) · Medical Oncology · doi:10.1007/s12032-022-01887-6 · Cited by 17
Systemic Delivery Strategies for Oncolytic Viruses: Advancing Targeted and Efficient Tumor Therapy
Xia, Y., Li, D., Yang, K., & Ou, X. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146900 · Cited by 18
Critical Roles of Tumor Extracellular Vesicles in the Microenvironment of Thoracic Cancers
Kara-Terki, L., Treps, L., Blanquart, C., & Fradin, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176024 · Cited by 16
Modulating osteoclasts with nanoparticles: A path for osteoporosis management?
Rouco, H., García‐García, P., Briffault, E., & Díaz‐Rodríguez, P. (2023) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1885 · Cited by 16
Zeng, M., Zhang, W., Li, Y., & Li, Y. (2024) · Biomarker Research · doi:10.1186/s40364-024-00581-1 · Cited by 17
Oncolytic Virus Therapy Alters the Secretome of Targeted Glioblastoma Cells
Godlewski, J. A., Farhath, M. M., Ricklefs, F. L., Passaro, C., Kiel, K., Nakashima, H., Chiocca, E. A., & Bronisz, A. (2021) · Cancers · doi:10.3390/cancers13061287 · Cited by 18
Islam, S. M. B. U., Lee, B., Jiang, F., Kim, E., Ahn, S., & Hwang, T.-H. (2020) · Cancers · doi:10.3390/cancers12010228 · Cited by 15
Muhammad, S. A., Mohammed, J. S., & Rabiu, S. (2023) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00878 · Cited by 14
Safarzadeh, M., Saadat, N., Abbasi-Molaei, S., & Rastegari‐Pouyani, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02283-z · Cited by 14
Extracellular Vesicles for Cancer Therapy: Impact of Host Immune Response
Gilligan, K., & Dwyer, R. M. (2020) · Cells · doi:10.3390/cells9010224 · Cited by 14
Shao, M., Rodrigues, J. D. S., Sousa‐Oliveira, I., Moradialvand, M., Asadollahi, P., Veiga, F., Hameed, H., Jha, N. K., Sillanpää, M. E. T., Sethi, G., et al. (2024) · Applied Materials Today · doi:10.1016/j.apmt.2024.102395 · Cited by 13
Zhang, W., Wang, J., Ngo, C. H. L., Li, L., & Wang, Y. (2025) · Advanced NanoBiomed Research · doi:10.1002/anbr.202500008 · Cited by 12
Nanotechnology and nano-sized tools: Newer approaches to circumvent oncolytic adenovirus limitations
Shirazi, M. M. A., Saedi, T. A., Moghaddam, Z. S., Nemati, M., شیری, ر., Negahdari, B., & Goradel, N. H. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108611 · Cited by 12
Delivery systems for enhancing oncolytic adenoviruses efficacy
Zhou, Y., Zhang, Y.-N., Yang, X., Wang, S., & Hu, P.-Y. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119971 · Cited by 12
Exploring AI tools and multi-omics for precision medicine in lung cancer therapy
Sahu, A., Nema, P., Rajak, D., Purohit, A., Rawal, R., Soni, V., & Kashaw, S. K. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.06.001 · Cited by 13
Oncolytic Viruses in Lung Cancer Treatment: A Review Article
Sakhi, H., Arabi, M., Ghaemi, A., Movafagh, A., & Sheikhpour, M. (2023) · Immunotherapy · doi:10.2217/imt-2023-0124 · Cited by 11
Combination therapy with oncolytic viruses for lung cancer treatment
Sun, L., Zhao, Q., & Miao, L. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1524079 · Cited by 11
Ipinmoroti, A. O., Crenshaw, B. J., Pandit, R., Kumar, S., Sims, B., & Matthews, Q. L. (2021) · Journal of Immunology Research · doi:10.1155/2021/2958394 · Cited by 11
Hochheuser, C., Kunze, N. Y., Tytgat, G. A. M., Voermans, C., & Timmerman, I. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030161 · Cited by 11
Metzner, C., & Zaruba, M. (2021) · Viruses · doi:10.3390/v13071238 · Cited by 11
Nanoengineering‐armed oncolytic viruses drive antitumor response: progress and challenges
Zhang, Y., Shi, X., Shen, Y., Dong, X., He, R., Chen, G., Zhang, Y., Tan, H., & Zhang, K. (2024) · MedComm · doi:10.1002/mco2.755 · Cited by 10
Kadbhane, A., Patel, M., Srivastava, S., Singh, P. K., Madan, J., Singh, S. B., & Khatri, D. K. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102526 · Cited by 10
Kiaheyrati, N., Babaei, A., Ranji, R., Bahadoran, E., Taheri, S., & Farokhpour, Z. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122734 · Cited by 11
Jamieson, T. R., Poutou, J., & Ilkow, C. S. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.07.004 · Cited by 10
Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors
Sharma, S., Rana, R., Prakash, P., & Ganguly, N. K. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04715-1 · Cited by 10
Owliaee, I., Khaledian, M., Boroujeni, A. K., & Shojaeian, A. (2023) · Infectious Agents and Cancer · doi:10.1186/s13027-023-00549-0 · Cited by 8
Therapeutic potential of oncolytic viruses in the era of precision oncology.
Kingsak, M., Meethong, T., Jongkhumkrong, J., Li, C., & Wang, Q. (2023) · PubMed Central · doi:10.12336/biomatertransl.2023.02.003 · Cited by 8
Muhammad, S. A., Mohammed, J. S., & Rabiu, S. (2022) · Pharmaceutical Nanotechnology · doi:10.2174/2211738510666220930155253 · Cited by 8
Sun, J., Ma, S., Xu, J., Abudureyimu, M., An, Y., Xu, J., Zhang, S.-H., Zhang, Z., Guo, C.-X., Liu, B.-L., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114514 · Cited by 8
Wang, X., Fan, R., Wang, G., Han, B., Zhou, L., Tong, A., Zou, B., & Guo, G. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101345 · Cited by 7
Taheri, B., Zarei‐Behjani, Z., Babaei, A., & Moradkhan, F. M. (2023) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-023-00295-0 · Cited by 7
Metadata
- Authors
- Garofalo, M., Saari, H., Somersalo, P., Crescenti, D., Kuryk, L., Aksela, L., Capasso, C., Madetoja, M., Koskinen, K., Oksanen, T., Mäkitie, A., Jalasvuori, M., Cerullo, V., Ciana, P., & Yliperttula, M.
- Affiliations
- University of Helsinki (FI)
- University of Milan (IT)
- University of Jyväskylä (FI)
- Corresponding author
- Garofalo, M.
- Yliperttula, M.
- ORCID
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2018-08
- Volume
- 283
- Pages
- 223-234
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2806319473
- Cited by
- 138
- References
- 77
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 17 · 2021: 22 · 2020: 28 · 2019: 9 · 2018: 5
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Controlled Release (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Työväentutkimus Vuosikirja (submittedVersion)
- Jyväskylä University Digital Archive (University of Jyväskylä) (submittedVersion, cc-by)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Funders
- Post doc pool foundation (016947-3)
- Italian Association for Cancer Research (IG-11903)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- oncolytic adenovirus, paclitaxel, extracellular vesicles, lung cancer, combination cancer therapy, intravenous drug delivery, xenograft tumor growth, gene expression profiling, differentially expressed genes, viral therapy
- MeSH terms
- Extracellular Vesicles, Animals, Antineoplastic Agents, Phytogenic, Combined Modality Therapy, Female, Humans, Liver, Lung Neoplasms, Mice, Inbred BALB C, Mice, Nude, Spleen, Paclitaxel, Cell Line, Tumor, Oncolytic Viruses
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
